drugset / Trial / NCT00061711
Alternative Therapies for Menopause: A Randomized Trial
RandomizedDouble-blindTreatment
Summary
This randomized, controlled trial will evaluate the efficacy and safety of three alternative approaches utilizing phytoestrogens to treat hot flashes and night sweats in peri- and post-menopausal women. The treatments were chosen because of the scientific evidence supporting a possible benefit, the availability of products with adequate quality control, and their frequency of use in naturopathic medicine. RECRUITMENT FOR THIS STUDY SHOULD END BY AUGUST 1, 2003.
Timeline
- Start
- 2000-07
- Primary completion
- 2005-12
- Completion
- 2005-12
Publications
- Background Newton KM, Buist DS, Keenan NL, Anderson LA, LaCroix AZ. Use of alternative therapies for menopause symptoms: results of a population-based survey. Obstet Gynecol. 2002 Jul;100(1):18-25. doi: 10.1016/s0029-7844(02)02005-7.
- Background Phelan EA, Buist DS, Anderson LA, Newton KM, Delaney KM, LaCroix AZ. Understanding attitudes of older women toward hormone replacement therapy. Prev Med. 2001 Jan;32(1):49-56. doi: 10.1006/pmed.2000.0768.
- Background Newton KM, LaCroix AZ, Leveille SG, Rutter C, Keenan NL, Anderson LA. Women's beliefs and decisions about hormone replacement therapy. J Womens Health. 1997 Aug;6(4):459-65. doi: 10.1089/jwh.1997.6.459.
- Background Newton KM, LaCroix AZ, Buist DS, Keenan NL. The use of alternative and complementary medicine by women enrolled in an HMO setting. Menopause, 1998, 5:244.
- Results Newton KM, Reed SD, Grothaus L, Ehrlich K, Guiltinan J, Ludman E, Lacroix AZ. The Herbal Alternatives for Menopause (HALT) Study: background and study design. Maturitas. 2005 Oct 16;52(2):134-46. doi: 10.1016/j.maturitas.2005.01.007.
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Black Cohosh | Traditional medicine (herbal / TCM) | 160 mg | — |
| Subject | Multibotanical phytoestrogen formula | Unknown | 50 mg | — |
| Subject | conjugated estrogens | Other / unclassified | 0.625 mg | — |
| Subject | medroxyprogesterone acetate | Other / unclassified | 2.5 mg | — |
Indications
No indication recorded.